Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Image-Enhanced Multi-Modal Contrastive Transformer for Subcellular Spatial Transcriptomics.

IEEE journal of biomedical and health informatics·2025
Same author

DeepPhosPPI: a deep learning framework with attention-CNN and transformer for predicting phosphorylation effects on protein-protein interactions.

Briefings in bioinformatics·2025
Same author

Identification of RC3H1 as antiviral host factor binding to the non-structural protein 1 of Influenza A virus via a 3-stage computational pipeline and cell-based analysis.

Virology journal·2025
Same author

Longitudinal analysis of retinal and choriocapillaris in patients with multiple sclerosis: a 3-year study.

Journal of neurology·2025
Same author

Systematic benchmarking of deep-learning methods for tertiary RNA structure prediction.

PLoS computational biology·2025
Same author

STCGAN: a novel cycle-consistent generative adversarial network for spatial transcriptomics cellular deconvolution.

Briefings in bioinformatics·2024

Related Experiment Video

Updated: May 12, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Automatic glaucoma diagnosis through medical imaging informatics.

Jiang Liu1, Zhuo Zhang, Damon Wing Kee Wong

  • 1Department of Ocular Imaging, Institute for Infocomm Research, Singapore, Singapore.

Journal of the American Medical Informatics Association : JAMIA
|March 30, 2013
PubMed
Summary

This study introduces AGLAIA-MII, an AI system for glaucoma screening that integrates personal data, retinal images, and genome information. It significantly improves diagnostic accuracy compared to methods using single data types.

Keywords:
Genome informationMedical Retinal Imageglaucomamedical imaging informaticsmultiple kernel learningpatient data

More Related Videos

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software
08:57

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software

Published on: September 4, 2021

Related Experiment Videos

Last Updated: May 12, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software
08:57

Quantification of Optic Nerve Cross Sectional Area on MRI: A Novel Protocol using Fiji Software

Published on: September 4, 2021

Area of Science:

  • Ophthalmology
  • Medical Imaging Informatics
  • Bioinformatics

Background:

  • Glaucoma is a leading cause of irreversible blindness, often undiagnosed due to a lack of effective screening.
  • Current screening methods are insufficient, leading to delayed treatment for over 50% of cases.

Purpose of the Study:

  • To develop an automated glaucoma diagnosis architecture, AGLAIA-MII, for enhanced screening.
  • To integrate diverse patient data including personal information, retinal images, and genomic data for improved diagnostic accuracy.

Main Methods:

  • A population study dataset of 2258 cases was utilized.
  • AGLAIA-MII employed a multiple kernel learning classifier.
  • The system integrated personal data, retinal image features, and single nucleotide polymorphism (SNP) data.

Main Results:

  • AGLAIA-MII achieved an area under the curve (AUC) of 0.866.
  • This performance surpassed individual data components (AUCs: 0.551 for personal data, 0.722 for images, 0.810 for genome SNPs).
  • AGLAIA-MII showed significant improvement over intraocular pressure-based screening.

Conclusions:

  • AGLAIA-MII is the first system to integrate personal, imaging, and genomic data for automated glaucoma screening in a large population.
  • This holistic approach offers a new standard for objective, automated glaucoma diagnosis and screening.